PharmTech LCGC Sciex Webinar 11.10
|Articles|March 6, 2009

Share repurchase program

Waters has announced that at the end of February 2009, its Board of Directors authorized the company to repurchase up to $500 million of its outstanding common shares over the next 24 months.

Waters has announced that at the end of February 2009, its Board of Directors authorized the company to repurchase up to $500 million of its outstanding common shares over the next 24 months.

A previous $500 million share repurchase program which had been authorized in February 2007 has expired, but was described by the company as “substantially completed”.

Purchases will be made through open market transactions, subject to market conditions and trading restrictions.

For more information about Waters, visit the company’s website at www.waters.com


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.